183 related articles for article (PubMed ID: 31377989)
1. Voxel-based morphometry results in first-episode schizophrenia: a comparison of publicly available software packages.
Li C; Liu W; Guo F; Wang X; Kang X; Xu Y; Xi Y; Wang H; Zhu Y; Yin H
Brain Imaging Behav; 2020 Dec; 14(6):2224-2231. PubMed ID: 31377989
[TBL] [Abstract][Full Text] [Related]
2. Patterns of regional gray matter loss at different stages of schizophrenia: A multisite, cross-sectional VBM study in first-episode and chronic illness.
Torres US; Duran FL; Schaufelberger MS; Crippa JA; Louzã MR; Sallet PC; Kanegusuku CY; Elkis H; Gattaz WF; Bassitt DP; Zuardi AW; Hallak JE; Leite CC; Castro CC; Santos AC; Murray RM; Busatto GF
Neuroimage Clin; 2016; 12():1-15. PubMed ID: 27354958
[TBL] [Abstract][Full Text] [Related]
3. Do preprocessing algorithms and statistical models influence voxel-based morphometry (VBM) results in amyotrophic lateral sclerosis patients? A systematic comparison of popular VBM analytical methods.
Rajagopalan V; Yue GH; Pioro EP
J Magn Reson Imaging; 2014 Sep; 40(3):662-7. PubMed ID: 24470336
[TBL] [Abstract][Full Text] [Related]
4. Disparate voxel based morphometry (VBM) results between SPM and FSL softwares in ALS patients with frontotemporal dementia: which VBM results to consider?
Rajagopalan V; Pioro EP
BMC Neurol; 2015 Mar; 15():32. PubMed ID: 25879588
[TBL] [Abstract][Full Text] [Related]
5. Gray matter volume changes following antipsychotic therapy in first-episode schizophrenia patients: A longitudinal voxel-based morphometric study.
Guo F; Zhu YQ; Li C; Wang XR; Wang HN; Liu WM; Wang LX; Tian P; Kang XW; Cui LB; Xi YB; Yin H
J Psychiatr Res; 2019 Sep; 116():126-132. PubMed ID: 31233895
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal loss of gray matter volume in patients with first-episode schizophrenia: DARTEL automated analysis and ROI validation.
Asami T; Bouix S; Whitford TJ; Shenton ME; Salisbury DF; McCarley RW
Neuroimage; 2012 Jan; 59(2):986-96. PubMed ID: 21924364
[TBL] [Abstract][Full Text] [Related]
7. Voxel-wise assessment of progression of regional brain atrophy in relapsing-remitting multiple sclerosis.
Battaglini M; Giorgio A; Stromillo ML; Bartolozzi ML; Guidi L; Federico A; De Stefano N
J Neurol Sci; 2009 Jul; 282(1-2):55-60. PubMed ID: 19286193
[TBL] [Abstract][Full Text] [Related]
8. [Cerebral grey matter changes of pre- and post-treatment in first-episode drug-naive adolescents schizophrenia].
Zhang L; Wang X; Zhang Y; Yang YF; Li WW; Li BL; Zhang D; Lü LX
Zhonghua Yi Xue Za Zhi; 2018 Oct; 98(37):2968-2972. PubMed ID: 30392249
[No Abstract] [Full Text] [Related]
9. What determines continuing grey matter changes in first-episode schizophrenia and affective psychosis?
Rosa PG; Zanetti MV; Duran FL; Santos LC; Menezes PR; Scazufca M; Murray RM; Busatto GF; Schaufelberger MS
Psychol Med; 2015 Mar; 45(4):817-28. PubMed ID: 25180801
[TBL] [Abstract][Full Text] [Related]
10. Regional brain gray and white matter changes in perinatally HIV-infected adolescents.
Sarma MK; Nagarajan R; Keller MA; Kumar R; Nielsen-Saines K; Michalik DE; Deville J; Church JA; Thomas MA
Neuroimage Clin; 2014; 4():29-34. PubMed ID: 24380059
[TBL] [Abstract][Full Text] [Related]
11. Whole brain volume changes and its correlation with clinical symptom severity in patients with schizophrenia: A DARTEL-based VBM study.
Kim GW; Kim YH; Jeong GW
PLoS One; 2017; 12(5):e0177251. PubMed ID: 28520743
[TBL] [Abstract][Full Text] [Related]
12. Progressive grey matter atrophy over the first 2-3 years of illness in first-episode schizophrenia: a tensor-based morphometry study.
Whitford TJ; Grieve SM; Farrow TF; Gomes L; Brennan J; Harris AW; Gordon E; Williams LM
Neuroimage; 2006 Aug; 32(2):511-9. PubMed ID: 16677830
[TBL] [Abstract][Full Text] [Related]
13. Cerebral gray matter volume losses in essential tremor: A case-control study using high resolution tissue probability maps.
Cameron E; Dyke JP; Hernandez N; Louis ED; Dydak U
Parkinsonism Relat Disord; 2018 Jun; 51():85-90. PubMed ID: 29574086
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional brain abnormalities in schizophrenia: A cross-sectional study at different stages of the disease.
Zhao C; Zhu J; Liu X; Pu C; Lai Y; Chen L; Yu X; Hong N
Prog Neuropsychopharmacol Biol Psychiatry; 2018 Apr; 83():27-32. PubMed ID: 29292241
[TBL] [Abstract][Full Text] [Related]
15. Voxel-based morphometric analysis of gray matter in first episode schizophrenia.
Kubicki M; Shenton ME; Salisbury DF; Hirayasu Y; Kasai K; Kikinis R; Jolesz FA; McCarley RW
Neuroimage; 2002 Dec; 17(4):1711-9. PubMed ID: 12498745
[TBL] [Abstract][Full Text] [Related]
16. A voxel-based morphometry comparison of the 3.0T ADNI-1 and ADNI-2 volumetric MRI protocols.
Brunton S; Gunasinghe C; Jones N; Kempton MJ; Westman E; Simmons A
Int J Geriatr Psychiatry; 2015 May; 30(5):531-8. PubMed ID: 25092796
[TBL] [Abstract][Full Text] [Related]
17. Association of cerebral deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized voxel-based morphometry and resting state functional connectivity study.
Lui S; Deng W; Huang X; Jiang L; Ma X; Chen H; Zhang T; Li X; Li D; Zou L; Tang H; Zhou XJ; Mechelli A; Collier DA; Sweeney JA; Li T; Gong Q
Am J Psychiatry; 2009 Feb; 166(2):196-205. PubMed ID: 18981063
[TBL] [Abstract][Full Text] [Related]
18. Gray matter volume reductions in patients with schizophrenia: A replication study across two cultural backgrounds.
Koelkebeck K; Dannlowski U; Ohrmann P; Suslow T; Murai T; Bauer J; Pedersen A; Matsukawa N; Son S; Haidl T; Miyata J
Psychiatry Res Neuroimaging; 2019 Oct; 292():32-40. PubMed ID: 31499256
[TBL] [Abstract][Full Text] [Related]
19. Onset of Schizophrenia Prior to the End of Brain Maturation Alters Grey Matter Volume Loss.
Ružić Baršić A; Gudelj L; Antulov R; Miletić D; Knežević K; Rubeša G
Psychiatr Danub; 2021; 33(Suppl 4):719-731. PubMed ID: 34718309
[TBL] [Abstract][Full Text] [Related]
20. Extensive brain structural network abnormality in first-episode treatment-naive patients with schizophrenia: morphometrical and covariation study.
Chen Z; Deng W; Gong Q; Huang C; Jiang L; Li M; He Z; Wang Q; Ma X; Wang Y; Chua SE; McAlonan GM; Sham PC; Collier DA; McGuire P; Li T
Psychol Med; 2014 Sep; 44(12):2489-501. PubMed ID: 24443827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
